The Importance of Identification of M-BCRABL Oncogene and JAK2^V617F Mutation in Myeloproliferative Neoplasms

Data publikacji: 25 kwi 2014

Zakres stron: 44 - 48

Otrzymano: 12 kwi 2013

Przyjęty: 31 mar 2014

DOI: https://doi.org/10.2478/amma-2014-0010

Słowa kluczowe

myeloproliferative neoplasms, JAK2V617F mutation, M-BCR-ABL oncogene

© by Z. Pávai

This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.